Acyline
- Generic Name
- Acyline
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C80H102ClN15O14
- CAS Number
- 170157-13-8
- Unique Ingredient Identifier
- S3439D3B35
- Background
Acyline has been investigated for the prevention and treatment of Hypogonadism and Contraception.
- Associated Conditions
- -
- Associated Therapies
- -
ACY-6 Oral Administration of Acyline
- First Posted Date
- 2007-05-09
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 9
- Registration Number
- NCT00471185
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
The Effects of Testosterone on Prostate Tissue (ACYP-1)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-09-19
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 13
- Registration Number
- NCT00161486
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-09-19
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 23
- Registration Number
- NCT00156650
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Male Hormonal Contraceptive Development-ACY-5
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-09-19
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 43
- Registration Number
- NCT00161447
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath